Palantir Plays Key Role in NIH’s Boldest Health Initiative

Key Takeaways

Palantir, a controversial data company linked to the Trump administration, is involved in the NIH’s All of Us health initiative.
Experts express ethical concerns regarding Palantir’s handling of sensitive health data due to its history with law enforcement and defense.
Despite assurances from NIH that Palantir’s role is limited, there are questions about the transparency of its involvement in the project.

Concerns Over Palantir’s Role in Health Data Initiative

In 2015, former President Barack Obama launched the Precision Medicine Initiative aimed at improving public health through personalized medicine. The National Institutes of Health (NIH) developed the All of Us initiative, which collects health data from up to one million Americans, with strict privacy measures to protect participants. As of now, nearly 750,000 participants have contributed data, which has facilitated important studies on diseases, including research revealing higher liver cancer rates among Latino immigrants.

However, ethical concerns have arisen about the involvement of Palantir Technologies, a firm known for its connections to the Trump administration and its data operations for Immigration and Customs Enforcement (ICE). Critics argue that it’s troubling for a company with such a background to handle sensitive health information. Despite this, Palantir’s participation has been made public through various press releases.

In 2023, Palantir was enlisted to assist with data management through the NIH’s Center for Linkage and Acquisition of Data at the University of North Carolina at Chapel Hill, primarily as a subcontractor. An NIH spokesperson emphasized that Palantir has no control over the data and operates under strict protocols to ensure privacy.

Nevertheless, industry experts and advocates have raised alarm over Palantir’s extensive role in managing diverse types of data across public health initiatives. They argue that participants in the All of Us project may not be fully informed about Palantir’s involvement or its implications. For instance, there have been inquiries regarding the transparency of consent forms used in recruiting study participants, which have not mentioned Palantir.

Critics like Katie Hasson from the Center for Genetics and Society and Kenny Morris of the American Friends Service Committee have echoed these concerns. They believe the public health community deserves to know the extent of Palantir’s involvement, especially given its history with military and law enforcement entities.

While Palantir asserts that it does not collect or sell data, the overarching sentiment remains that health data should be managed by organizations committed to public welfare. As awareness of Palantir’s role grows, questions regarding data use and transparency continue to loom over the All of Us initiative, highlighting the complex intersection of technology, privacy, and public health.

The content above is a summary. For more details, see the source article.